30 closest matches · ranked by relevance
Healthy
Primary: Baseline Corrected Maximum Observed Plasma Concentration (Cmax[Adj]) of Levothyroxine Sodium — 67.258; 60.552 Nanogram per milliliter (ng/mL)
Healthy
Primary: AUC0-tz — 300; 310; 306 ng*h/mL — p=<0.0001
Healthy
Primary: Area Under the Concentration-time Curve of Nerandomilast in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 1270.92; 1320.24…
Prostatic Hyperplasia
Primary: Maximum Measured Concentration (Cmax) — 8826; 8856 pg/mL
Healthy
Primary: Maximum Observed Plasma Concentration of Hyoscine Butylbromide (Cmax) — 91; 80 picogram (pg)/millilitre (mL)
Healthy
Primary: Area Under the Concentration-time Curve of Nerandomilast in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 2275.77; 2166.70…
Healthy
Primary: Letrozole : AUC0-tz — 2074.71; 2094.63 ng•hr/mL
Prostatic Hyperplasia
Primary: Cmax — 21700; 20520 pg/mL
Hereditary Tyrosinemia, Type I
Primary: Maximum Observed Plasma Concentration (Cmax) — 1277.77; 1272.34; 1339.79 ng/mL
Healthy
Primary: Maximum Plasma Concentration (Cmax) — 265.96; 260.04 ng/ml
Type 2 Diabetes Mellitus
Primary: Area Under the Curve (AUC(0 to Infinity)) Following Single Dose Administration of the Anhydrous and Monohydrate Forms of MK0431 (Sitagliptin) — 8.38; 8.78 μmol*hr/L
Healthy
Primary: Maximum Serum Concentration in Pre Dose Corrected Data (Cmax[aj]) of Levothyroxine (T4) — 67.24; 66.44 nanogram per milliliter (ng/mL)
Bacterial Infection
Primary: Maximum Plasma Concentration (Cmax) of Doxycycline — 2.526; 2.442 ug/mL
Healthy
Primary: Part A, B and C: Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration (AUC 0-t) of Tepotinib — 16146; 18645; 12609; 23457…
Healthy
Primary: Maximum Plasma Concentration (Cmax) — 270.31; 248.46 ng / ml
Hereditary Tyrosinemia, Type I
Primary: Maximum Observed Plasma Concentration (Cmax) — 1137.40; 1080.69; 1168.71 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 536; 543 ng/mL
Bioequivalence
Primary: Androxal Cmax Formulation A — 0.999; 1.67 ng/mL
Healthy
Primary: Area Under the Concentration-time Curve of BI 1358894 in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 7360; 14700; 8430; 14900…
Hypogonadism
Primary: The Area Under the Curve From Time Zero to Last Quantifiable Concentration [AUC (0-t)] of Testosterone Enanthate Formulations at 6 Weeks — 150445.2; 70955.7; 278657.9…
Healthy
Primary: Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration (AUC0-t) of Tepotinib — 15348; 16523 Hours*nanogram per milliliter…
Bioequivalence
Primary: Concentration Maximum (Cmax) — 0.9092; 0.8711 ng/ml
Healthy
Primary: Maximum Measured Concentration (Cmax) of the Analytes in Plasma — 697; 726; 3.62; 3.57 ng/mL
Healthy
Primary: Area Under the Concentration-Time Curve From Zero Time Until the Last Sampling Time (AUCt) — 126.36; 129.48; 122.33; 119.75 ng*h/mL
Dyslipidemia
Primary: Area Under the Curve (AUC(0 to Infinity)) of Fenofibric Acid — 116; 121 μg·hr/mL
Bioequivalence
Primary: Concentration Maximum (Cmax) — 1.326; 1.293 ng/ml
Healthy
Primary: Cmax - Maximum Observed Concentration - Terbinafine in Plasma — 906; 971 ng/mL
Hypercholesterolemia
Primary: Area Under the Curve From Predose (Time Zero) to 48 Hours Post-dose (AUC48) — 135.05; 140.79 ng.h/mL
Healthy
Primary: Area Under the Curve 0 to Infinity (AUC0-∞) — 5200; 5090 nmol*h/L
Smoking Cessation
Primary: Area Under the Plasma Concentration Versus Time Curve From Time Zero to Time t [AUC(0-t)] — 18.84; 20.71; 34.71; 33.68 nanogram (ng).hour (hr)/millilitre (mL)